Azmi Nasser

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Topics

Emergency Department

Psychometric Properties

Top Venues

Journal of pharmacokinetics and pharmacodynamics

Brain and behavior

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Azmi Nasser, Roberto Gomeni, Gianpiera Ceresoli-Borroni, Lanyi Xie, Gregory D Busse, Zare Melyan, Jonathan Rubin
Model-based comparison of subcutaneous versus sublingual apomorphine administration in the treatment of motor fluctuations in Parkinson's disease. Journal of pharmacokinetics and pharmacodynamics 51 (4) (2024)
Azmi Nasser, Roberto Gomeni, Gianpiera Ceresoli-Borroni, Lanyi Xie, Gregory D Busse, Zare Melyan, Jonathan Rubin
Model-based comparison of subcutaneous versus sublingual apomorphine administration in the treatment of motor fluctuations in Parkinson's disease. Journal of pharmacokinetics and pharmacodynamics (2024)
Azmi Nasser, Roberto Gomeni, Gianpiera Ceresoli-Borroni, Lanyi Xie, Gregory D Busse, Zare Melyan, Jonathan Rubin
Model-based comparison of subcutaneous versus sublingual apomorphine administration in the treatment of motor fluctuations in Parkinson's disease. Journal of pharmacokinetics and pharmacodynamics (2024)
Azmi Nasser, Roberto Gomeni, Gianpiera Ceresoli-Borroni, Lanyi Xie, Gregory D Busse, Zare Melyan, Jonathan Rubin
Model-based comparison of subcutaneous versus sublingual apomorphine administration in the treatment of motor fluctuations in Parkinson's disease. Journal of pharmacokinetics and pharmacodynamics 51 (4) (2024)
Azmi Nasser, Roberto Gomeni, Gianpiera Ceresoli-Borroni, Lanyi Xie, Gregory D Busse, Zare Melyan, Jonathan Rubin
Model-based comparison of subcutaneous versus sublingual apomorphine administration in the treatment of motor fluctuations in Parkinson's disease. Journal of pharmacokinetics and pharmacodynamics (2024)
Azmi Nasser, Roberto Gomeni, Gianpiera Ceresoli-Borroni, Lanyi Xie, Gregory D Busse, Zare Melyan, Jonathan Rubin
Model-based comparison of subcutaneous versus sublingual apomorphine administration in the treatment of motor fluctuations in Parkinson's disease. Journal of pharmacokinetics and pharmacodynamics 51 (4) (2024)
Azmi Nasser, Roberto Gomeni, Gianpiera Ceresoli-Borroni, Lanyi Xie, Gregory D Busse, Zare Melyan, Jonathan Rubin
Correction: Model-based comparison of subcutaneous versus sublingual apomorphine administration in the treatment of motor fluctuations in Parkinson's disease. Journal of pharmacokinetics and pharmacodynamics (2024)
Stephen V Faraone, Roberto Gomeni, Joseph T Hull, Gregory D Busse, Brendan Lujan, Jonathan Rubin, Azmi Nasser
Response of peer relations and social activities to treatment with viloxazine extended-release capsules (Qelbree ® ): A post hoc analysis of four randomized clinical trials of children and adolescents with attention-deficit/hyperactivity disorder. Brain and behavior (2023)
Azmi Nasser, Roberto Gomeni, Zhao Wang, Joseph T Hull, Gregory D Busse, Zare Melyan, Maurizio Fava, Welton O'Neal, Jonathan Rubin
The role of placebo response in the efficacy outcome assessment in viloxazine extended-release pivotal trials in paediatric subjects with attention-deficit/hyperactivity disorder. British journal of clinical pharmacology 88 (11) (2022)